NCT04391959 - Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

January 6, 2021

Study Completion Date

January 6, 2021

Conditions

Meibomian Gland Dysfunction

Interventions

DRUG

AZR-MD-001 Active

AZR-MD-001 is an active ophthalmic ointment

DRUG

AZR-MD-001 Vehicle

AZR-MD-001 is a vehicle ophthalmic ointment

Trial Locations (5)

Fiona Stapleton, Sydney

Scott A Read, Brisbane

Susan Thackwray, Maroochydore

Jagrut Lallu, Auckland

Jennifer P Craig, Auckland